MINNEAPOLIS, March 17, 2016 /PRNewswire/ — OneOme, LLC, a pharmacogenomics company, announced today the hiring of Dr. Justin Odegaard, M.D., Ph.D. and Ross Higgins to manage and lead their pharmacogenomics testing laboratory. Both Dr. Odegaard and Mr. Higgins bring extensive background in laborato...
Wall Street Journal: Is your medicine right for your metabolism?
03/14/2016
The Wall Street Journal published an article explaining the benefits of pharmacogenomic testing. Pharmacogenomics identifies which inherited genetic variations a person has and predicts how an individual will — or will not — respond to specific medications.
Because everyone responds to drugs di...
OneOme prepares for commercial launch in new state-of-the-art facility
02/16/2016
MINNEAPOLIS, Minnesota—OneOme, LLC, a pharmacogenomics company, announced today that it will move its corporate office and clinical laboratory to the Highlight Center in northeast Minneapolis in early 2016. The new location will expand OneOme’s operations with a high-throughput clinical laborato...
OneOme Appoints Paul Owen as Chief Operating Officer
09/18/2015
MINNEAPOLIS, Minnesota—OneOme, LLC, a pharmacogenomics company, recently announced that it appointed Paul Owen as its Chief Operating Officer.
Troy Kopischke, CEO, stated: “Owen’s experience and expertise in pharmacogenomics are incredible assets for OneOme. His leadership will drive OneOme...
OneOme analyzes first genetic data from Mayo Clinic patients, delivers first reports
06/23/2015
MINNEAPOLIS, Minnesota—OneOme, LLC, a pharmacogenomics company, recently analyzed genetic data from the first two patients using the PGxExpress product developed in collaboration with Mayo Clinic. Both analyses were delivered successfully in the form of comprehensive reports to the patients throug...
